Trial Profile
A study of efficacy and safety of landiolol hydrochloride for pulmonary resection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Arrhythmias; Atrial fibrillation; Atrial flutter; Coronary disorders; Supraventricular tachycardia; Ventricular arrhythmias
- Focus Therapeutic Use
- 29 Oct 2018 Status changed from active, no longer recruiting to completed.
- 04 Oct 2017 New trial record